Monthly Archives: October 2016

Tempi Mechanical Metronome Rocks Out with Rock Music

Tempi LLC’s mechanical metronome helps aspiring rockers achieve musical success.

Charlotte, United States – October 31, 2016 /PressCable/ —

Music has gone a long way since men started pounding their fist on objects to make a sound, with each beat producing sounds that have meaning. Since then, different types and styles from traditional to world pop was born. Today, there is 1,264 genres of popular music; many of which have mutated in form from their roots even before the 20th century. Changes in musical trends have been affected by significant events in the history of mankind. However, throughout these upheavals, there was something constant in the music produced – the beat, the rhythm and the pace.

In the early 9th century, the mechanical metronome was introduced as a device to regulate a set of beats per minute at a fixed and regular pulse to which musicians could pace themselves when playing their instruments.

Throughout the years, neophytes and professional musicians learned to hone their skills in making music with the mechanical metronome. Today, there are three kinds of metronome; mechanical, electronic and software, but the mechanical metronome is still the choice of both beginners and professional music players. When talking about which is the best metronome in the market, a lot of them often recommend the Tempi Mechanical Metronome for its precision, and durability.

Rock music, the most popular music genre, relies on the mechanical metronome and Tempi Mechanical Metronome is the one of the most recommended in the market. It is easy to operate, has precise timing, proper pace and a steady rhythm. It is capable of generating an average of 20 minute wind of continuous practice at 40 – 208 bpm for each one wind. Its pyramidal shape and solid base ensures a stable production of rhythm even if the surrounding area is vibrating from the sounds of rock music. Its packaging is stylish and durable, and will suit any setting – be it at a rock concert or a music room.

The Tempi Mechanical Metronome is here to stay because it is known for its endurance to survive any changes the music industry will make. Its consistency of pace and tempo, strength, precision in musical timing will make it the choice of future musician as well.

For every purchase of the Tempi Mechanical Metronome comes a bonus e-book, “10 Tips to Help Any Musician Succeed,” to help musicians achieve success in their endeavor. All Tempi Mechanical Metronome also comes with a two-year manufacturer’s warranty, and a 30-day satisfaction warranty.

About Tempi LLC: Tempi LLC, is a US based company that is dedicated in helping music lovers, beginners and musicians achieve success. All of their products are created in line with the philosophy: “offer elegant, superior products that have the potential to provide exceptional musical success.” They pride themselves on keeping ahead of the industry with their continuous research and drive to improve. Learn more by visiting:

For more information, please visit

Contact Info:
Name: Jamie Hill
Organization: Tempi LLC
Address: Charlotte NC

Release ID: 142291

Altima Announces Change of Officer

VANCOUVER, BC / ACCESSWIRE / October 31, 2016 / Altima Resources Ltd. (TSXV: ARH) (FSE: AKC) (OTC Pink: ARSLF) announces that Joe DeVries has been appointed as Interim Chief Executive Officer and President of the Company, replacing Richard Switzer, who has notified the Company of his desire to retire from active involvement. The Company wishes to thank Mr. Switzer for his ten years of service as CEO, President and director.

For clarification, the Company’s Officers and Directors are currently comprised of the following:

Joe DeVries, Interim President and Chief Executive Officer, and Director
Richard Barnett, Secretary and Chief Financial Officer
Jim O’Byrne, Chairman and Director
Stephen Watts, Director
Jurgen Wolf, Director


SIGNED: “Richard Barnett”

Richard Barnett, CFO
Contact: (604) 336-8610

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes certain forward-looking statements or information. All statements other than statements of historical fact included in this release are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s plans or expectations include risks relating to: availability of capital and financing required to continue the Company’s exploration and development plans; general economic, market or business conditions; the actual results of current and planned exploration activities; fluctuating commodity prices; risks associated with property option agreements, leases, joint ventures and the ability to conclude joint venture agreements on favorable terms; possibility of accidents, equipment breakdowns and delays during exploration; exploration cost overruns or unanticipated costs and expenses; regulatory changes and restrictions including in relation to environmental liability; timeliness of government or regulatory approvals and other risks detailed herein and from time to time in the filings made by the Company with securities regulators. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise except as otherwise required by applicable securities legislation.

SOURCE: Altima Resources Ltd.

ReleaseID: 448015

INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Pilgrim’s Pride Corporation and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / October 31, 2016 / Khang & Khang LLP (the “Firm”) announces a class action lawsuit against Pilgrim’s Pride Corporation (“Pilgrim’s Pride” or the “Company”) (Nasdaq: PPC). Investors who purchased or otherwise acquired shares between February 21, 2014 and October 6, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the December 19, 2016 lead plaintiff motion deadline.

If you purchased Pilgrim’s Pride shares during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that Pilgrim’s Pride made false and/or misleading statements and/or failed to disclose that: the Company systematically colluded with several of its industry peers to fix prices in the market for broiler chickens; that the foregoing conduct constituted a violation of federal antitrust laws; that Pilgrim’s Pride’s revenues during the class period were the result of illegal conduct; that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. On October 7, 2016, Pivotal Research downgraded its peer company Tyson Foods, Inc. from “buy” to “sell,” due to fears of a class action against Tyson Foods, Pilgrim’s Pride other peers over price collusion in the broiler-chicken market. Allegedly, in 2008, Tyson Foods, Pilgrim’s Pride, and several other companies conspired by sharing proprietary data and reducing production to support prices. When this information was disclosed, the stock price of Pilgrim’s Pride fell.

If you wish to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at

This press release may constitute Attorney Advertising in some jurisdictions.


Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474

SOURCE:Khang & Khang LLP

ReleaseID: 448012

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 31, 2016 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Seres Therapeutics, Inc. (“Seres Therapeutics” or the “Company”) (Nasdaq: MCRB) concerning possible violations of federal securities laws between June 25, 2015 and July 29, 2016 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm in advance of the November 28, 2016 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The complaint alleges that throughout the Class Period, Seres Therapeutics made materially false and misleading statements and/or failed to disclose material facts about its lead drug product candidate SER-109, touting its potential and efficacy. On July 29, 2016, the Company announced that the Phase 2 clinical trial of SER-109 did not meet its primary endpoint. When this information was disclosed to the public, the stock price of Seres Therapeutics declined, which caused investors harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.


Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125

SOURCE: Lundin Law PC

ReleaseID: 448011

Dawson James Securities Announces the Completion of $5.2 Million Underwritten Offering for Tonix Pharmaceuticals

BOCA RATON, FL / ACCESSWIRE / October 31, 2016 / Dawson James Securities, Inc. in conjunction with Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) announced the closing on October 31st of an underwritten public offering of 9,500,000 units, consisting of 9,500,000 shares of common, and warrants to purchase an aggregate of 4,750,000 shares of common stock, at an offering price of $0.55 per unit. Dawson James also purchased additional warrants to acquire 712,500 common shares pursuant to the over-allotment option exercised in part by Dawson James. The warrants have an exercise price of $0.63 per share and are exercisable for a period of five years. The units were sold at the public offering price of $0.55 per unit, bringing the aggregate gross proceeds from the offering to $5.2 million, before deducting underwriting discounts and commissions and other offering expenses.

Dawson James Securities, Inc. acted as the sole book-running manager for the offering.

“We are pleased to provide the capital necessary for the Company to support the continued development and phase 3 studies of TNX-102 SL for the treatment of posttraumatic stress disorder (PTSD),” said Robert D. Keyser, Dawson James CEO. Tonix intends to utilize the net proceeds of the offering for general working capital and to further develop other pipeline programs.

The shares described above were offered by Tonix pursuant to a registration statement previously filed with and subsequently declared effective by the Securities and Exchange Commission (“SEC”). A final prospectus supplement relating to the offering was filed with the SEC and is available, along with the accompanying base prospectus, on the SEC’s website at, or by contacting Dawson James: 1 N. Federal Hwy; Suite 500, Boca Raton, FL 33432 ATTN: Prospectus Department.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Tonix Pharmaceuticals Holding Corp.

Tonix is developing next-generation medicines for common disorders of the central nervous system, with its lead program focusing on posttraumatic stress disorder. This disorder is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and significant economic burden. This press release and further information about Tonix can be found at

About Dawson James Securities

Dawson James Securities specializes in capital raising for small and microcap public and private growth companies primarily in the Life Science/Health Care, Technology and Consumer sectors and is a full service investment banking firm with research, institutional and retail sales, and execution trading and corporate services. Headquartered in Boca Raton, FL, Dawson James is privately held with offices in New York, California, Maryland and New Jersey and North Carolina.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A Of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes”, “expects”, “anticipates” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.


For more information, please contact:

Elise Stern, Managing Director, Head of Capital Markets

SOURCE: Dawson James Securities, Inc.

ReleaseID: 448007

Buy Probate Houses Fast Establish Property Business Advice Guide Launched

A new guide to getting into probate property buying and selling has been launched by Ron Mead, helping newcomers to the industry to get established. It offers step by step instructions to start buying and selling immediately.

Pleasant Prairie, United States – October 31, 2016 /PressCable/ —

Ron Mead has launched a new guide to buying probate houses as a way to help more people establish themselves in the industry through getting expert guidance in the field. Called 31 Days to Profits in Probate Real Estate, it is a step by step guide that shows people how to establish themselves, make their first purchase, and develop that into a longstanding business.

More information can be found at:

Probate property is the property that has been left to someone after the owner of the building has passed away. This means that whoever has been given control of the property has the responsibility of still paying taxes on that property, and most people do not want to be stuck with this.

Buyers who can locate probate properties and engage with the owners quickly and efficiently can therefore make fast cash purchases to help the owner get rid of unwanted property.

The guide establishes a series of criteria that form the foundation of any probate buying enterprise. It emphasises that people make their business work by buying property, so it stands to reason that anyone entering the industry should strive to find people who will sell their property for less than market value.

In the 31 Days guide, readers can discover how they can get in touch with clients who need to sell their house, and sell it quickly. The goal is to find a way to make the purchase without any competition, as opposed to buying highly competitive property where continuous bids can drive the price up. Ron Mead says that one of the benefits of buying probate property is that if buyers act quickly, they can be the only game in town.

Another benefit of the guide is the step by step education process. For newcomers to the industry, it can often be confusing to dive right in. In 31 Days, readers have someone who can take the lead and show them how a professional works each day to buy their own personal probate properties.

Full details of the guide can be found in a detailed review here:

For more information, please visit

Contact Info:
Name: Ron Johnson
Organization: RJDK Enterprise
Address: 8767 3rd ave

Release ID: 142239

DEADLINE TODAY: Lundin Law PC Announces Securities Class Action Lawsuit against American Renal Associates Holdings, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 31, 2016 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against American Renal Associates Holdings, Inc. (“ARA” or the “Company”) (NYSE: ARA) concerning possible violations of federal securities laws. Investors who purchased or otherwise acquired shares 1) pursuant and/or traceable to the Initial Public Offering (“IPO”) on or about April 21, 2016; and/or 2) on the open market between April 21, 2016 and August 18, 2016 (the “Class Period”), should contact the firm by the October 31, 2016 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The complaint alleges that ARA issued false and misleading statements to investors and/or failed to disclose that: ARA was engaged in a fraudulent scheme to steer patients away from Medicare and Medicaid plans they qualified for, into more expensive Affordable Care Act plans to obtain greater reimbursement for its dialysis services; the scheme was in violation of federal and state laws; and as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this information emerged, ARA’s stock price declined, causing investors harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.


Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

SOURCE: Lundin Law PC

ReleaseID: 448009

Suitable Blood Pressure Monitor Among Items Required to Help Treat Hypertension Without Pills

October 31, 2016 – –

With statistics indicating that well over 16 million Americans who take high blood pressure medication still do not have the disease under control, a number of medical experts suggest using natural treatments to help counter its effects.

In addition to lifestyle changes, including healthier diets, exercise, and meditation, a suitable blood pressure monitor is also recommended for people who decide to treat hypertension without taking pills. A good monitor allows patients to keep track of any changes, up or down, since blood pressure levels can increase or decrease without any warning. Experts also recommend portable monitors that can be used anywhere and anytime for people who do home tests or while on the go.

Just Brill’s DigiPulse, a digital blood pressure monitor available on, is among many that are considered useful to people who want to treat hypertension without taking prescribed drugs. The product comes with a number of features and benefits that help patients keep on top of their blood pressure levels.

For starters, it is rated highly among users for accuracy, once the directions for use are followed. Accuracy is one of the most important attributes a blood pressure monitor can have, as a wrong reading can mean the difference between life and death.

Additionally, the DigiPulse comes with a large LCD display that makes it easy for the reading to be seen, and has a comfortable cuff that is fitted to the wrist by way of a low-noise pump. The blood pressure monitor also comes with a convenient memory-recall feature that allows up to 60 readings to be stored so that users can track and compare readings.

Numerous shoppers on Amazon have given the DigiPulse Wrist Cuff Monitor high praises after using it to keep on top of their hypertension. “Great product, accurate, easy to use & you can bring anywhere you want when travelling. Prompt delivery, great customer service, seller is really nice & they make sure the customer will be satisfied,” said Cfraz, a verified Amazon reviewer.

The blood pressure monitor from Just Brill is among those that are growing in popularity as more people try to treat hypertension naturally. The device is available to shoppers on Amazon and comes with free batteries and a carrying case.


Contact Just-Brill LTD:

Just-Brill LTD
Just-Brill LTD
5a The Broadway
Brighton, East Sussex
United Kingdom BN2 5NF

ReleaseID: 60013015

Vancouver, Washington Company Promotes Defense In Light Of The Upcoming Flu Season

October 31, 2016 – – in Vancouver, Washington, wants to help people get through the upcoming flu season without getting sick. In order to achieve this, the company is promoting its My BioDefense Sanitizing Wand and App.

Jillian Gregg, a spokesperson for the company, says, “One of the best ways to avoid contracting the flu or any spreadable illness is to sanitize. Our wand and app are designed specifically for that purpose.”

Gregg explains that the company’s sanitizing wand helps to kill up to 99 percent of all germs, which effectively helps households boost their efforts in fighting against the flu. The company’s MyBioDefense App is designed to work with the wand, both of which can be ordered from the Amazon marketplace. Meanwhile, in addition to promoting the mentioned products, the company also wanted to provide an update for health care providers for fighting influenza from the Center For Disease Control and Prevention (CDC).

“If we could get people and physicians using the sanitizing wand,” says Gregg, “we may just be able to spend a season without hospitals filling up and people getting really sick due to the newest strain.”

The CDC has reported several hundred cases of influenza infection with parotitis during the 2014-2015 flu season. The CDC stated that previously only about a dozen or so cases were reported where parotitis followed the influenza infection. The organization states that while it can be found in patients of all ages, it is very common in school aged children and in males, and it appears to occur more with certain strains of the flu virus.

The CDC has also reported that cases of parotitis have grown substantially this year, and that physicians as well as people should take steps to ensure that they are protecting themselves, their patients, and their families from these often serious strains of the flu virus. Gregg says that her company fully agrees with protection and urges everyone to consider sanitizing as a defense against the virus.

She says that the MyBioDefense wand can kill germs, eliminating the risk for flu virus infection, which is particularly important this year as the CDC has confirmed that the flu virus is alive and well and should begin its path of destruction in the next few weeks.



Jillian Gregg
PO Box 1539
Vancouver, Washington 98668

ReleaseID: 60012937

Search Engine Optimization Expert Offers Video Audit Presentation

October 31, 2016 – – Find My Biz Online offers a review and upgrade of customer websites who are looking for ways to increase online presence. The SEO authority utilizes legal and effective means to enhance website traffic for customers.

Providence RI: Find My Biz Online owner Jude Ahamiojie is pleased to announce that they now offer a free video presentation to customers. The topic is the audit of the customer website and its effectiveness in utilizing the top search engine optimization techniques. Entrepreneurs know the importance of good website design, utilizing optimization methods, in order to get their site ranked by the major search engines. Jude has the expertise to help clients improve their business results through online techniques and design.

According to Jude Ahamiojie, “Regardless of the type of venture or business, you are in, online visibility is the key to success. SEO methods are the basis of visibility. My company can help you with the efforts to achieve success. We do this by implementing the most effective and powerful strategies on the website, as well as offline.”

“Google needs to know two things about you” he continues. “You must be relevant for the keywords which are part of your money ranking links. You must also be a trustworthy and authoritative dispenser of information about the product or service which you provide. Searchers on Google or other major search engines must be able to depend on the information you provide.”

The Rhode Island optimization expert explains that unless the business or organization website is on the first page of search results, the likelihood of searchers finding the business is significantly lower. The services which Jude offers bring balance to the results so that his clients see improved results in traffic as well as in revenues from the traffic.

Search engine optimization is the answer to underperforming websites and weak revenues, Ahamiojie says. The process tune-up the website and related factors in order to tell the search engines that the website is the authoritative one for the search results. He adds that professional expertise is best able to accomplish the results which businesses need.


Contact Find My Biz Online:

Jude Ahamiojie
106 Knight st Providence, RI 02909

ReleaseID: 60013019